Intravitreal anti-VEGF therapy

VEGF inhibitor

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Intravitreal anti-VEGF therapy, covering 2013-05-03 to 2025-03-17. Get the full timeline:

Most recent: Clinical Trial Update: Change in Ocular Perfusion After Intravitreal Anti-VEGF in Patients with Age-related Maculopathy or Diabetic Macula Edema

See pricing